Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,496Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Faran Shimi Pharmaceutical

02 1ACORDA THERAPEUTICS IRELAND LIMITED

03 1Accord healthcare

04 1Acino Pharma (Pty) Ltd

05 1Actavis Inc

06 1Alkem Laboratories

07 1Ascent Innovative Medicines

08 1Aurobindo Pharma Limited

09 6Biogen

10 4CHEMO

11 1CinnaGen Co

12 1Hikma Pharmaceuticals

13 1Intas Pharmaceuticals

14 1MERZ

15 1Micro Labs Limited

16 1Neuraxpharm

17 2ORIFARM GROUP AS

18 1Pharmascience Inc.

19 1Rising Pharmaceuticals Inc

20 1Sun Pharmaceutical Industries Limited

21 1Taro Pharmaceutical Industries

22 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Regulatory Info :

Registration Country : Iran

Fampridine

Brand Name :

Dosage Form : Extended-Release Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

Faran Shimi Pharmaceutical

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2018-07-11

Application Number : 206863

Regulatory Info : RX

Registration Country : USA

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2017-01-23

Application Number : 206836

Regulatory Info : RX

Registration Country : USA

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2018-07-30

Application Number : 206765

Regulatory Info : RX

Registration Country : USA

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2017-01-23

Application Number : 206811

Regulatory Info : RX

Registration Country : USA

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

fampridine

Brand Name : Fampyra

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 10 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

11

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

12

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Dalfyra

Dosage Form : Tablet ER.

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

13

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2018-10-24

Application Number : 206646

Regulatory Info : DISCN

Registration Country : USA

blank

14

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2019-03-11

Application Number : 210158

Regulatory Info : RX

Registration Country : USA

blank

15

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

16

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2020-07-06

Application Number : 206858

Regulatory Info : DISCN

Registration Country : USA

blank

18

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2019-05-21

Application Number : 208292

Regulatory Info : RX

Registration Country : USA

blank

19

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 206854

Regulatory Info :

Registration Country : USA

blank

20

MERZ

Country
AACR Annual meeting
Not Confirmed
arrow

MERZ

Country
arrow
AACR Annual meeting
Not Confirmed

DALFAMPRIDINE

Brand Name : AMPYRA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2010-01-22

Application Number : 22250

Regulatory Info : RX

Registration Country : USA

blank